Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1144

1.

Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.

Frasure-Smith N, Lespérance F, Habra M, Talajic M, Khairy P, Dorian P, Roy D; Atrial Fibrillation and Congestive Heart Failure Investigators.

Circulation. 2009 Jul 14;120(2):134-40, 3p following 140. doi: 10.1161/CIRCULATIONAHA.109.851675. Epub 2009 Jun 29.

2.

Digoxin and mortality in atrial fibrillation: a prospective cohort study.

Hallberg P, Lindbäck J, Lindahl B, Stenestrand U, Melhus H; RIKS-HIA group.

Eur J Clin Pharmacol. 2007 Oct;63(10):959-71. Epub 2007 Aug 8.

PMID:
17684738
3.

Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ.

Circulation. 2003 Jun 17;107(23):2920-5. Epub 2003 May 27.

4.

Relationship of depression to death or hospitalization in patients with heart failure.

Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF Jr, Dupree CS, Waugh RA, Bensimhon DR, Gaulden L, Christenson RH, Koch GG, Hinderliter AL.

Arch Intern Med. 2007 Feb 26;167(4):367-73.

PMID:
17325298
5.

Prognostic value of anxiety and depression in patients with chronic heart failure.

Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, Gaulden LH, Califf RM, Krishnan RR, O'Connor CM.

Circulation. 2004 Nov 30;110(22):3452-6. Epub 2004 Nov 22.

6.

Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure.

Wojtkowska I, Sobkowicz B, Musiał WJ, Kozuch M.

Kardiol Pol. 2006 Aug;64(8):777-83; discussion 784-5.

7.

Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

Frasure-Smith N, Lespérance F, Talajic M, Khairy P, Dorian P, O'Meara E, Roy D.

Circ Heart Fail. 2012 May 1;5(3):322-30. doi: 10.1161/CIRCHEARTFAILURE.111.964122. Epub 2012 Mar 22.

8.

Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):645-9.

PMID:
15990747
9.

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O'Connor CM.

Arch Intern Med. 2001 Aug 13-27;161(15):1849-56.

PMID:
11493126
10.

Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D; AF-CHF investigators.

Circ Heart Fail. 2012 Sep 1;5(5):586-93. Epub 2012 Jul 12.

11.

Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.

Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam MA, Yusuf S.

Am J Cardiol. 1996 Oct 15;78(8):890-5.

PMID:
8888661
12.

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA; CHARM Investigators.

J Am Coll Cardiol. 2006 May 16;47(10):1997-2004. Epub 2006 Apr 27.

13.
14.

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.

Middlekauff HR, Stevenson WG, Stevenson LW.

Circulation. 1991 Jul;84(1):40-8.

PMID:
2060110
16.

Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.

Demir M, Kanadasi M, Akpinar O, Dönmez Y, Avkarogullari M, Alhan C, Inal T, San M, Usal A, Demirtas M.

Angiology. 2007 Oct-Nov;58(5):603-9.

PMID:
18024945
17.

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG.

J Am Coll Cardiol. 1992 Sep;20(3):527-32.

PMID:
1512329
18.

Depressive symptoms predict recurrence of atrial fibrillation after cardioversion.

Lange HW, Herrmann-Lingen C.

J Psychosom Res. 2007 Nov;63(5):509-13.

PMID:
17980224
19.

Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database).

Baldasseroni S, De Biase L, Fresco C, Marchionni N, Marini M, Masotti G, Orsini G, Porcu M, Pozzar F, Scherillo M, Maggioni AP; Italian Network on Congestive Heart Failure.

Eur Heart J. 2002 Nov;23(21):1692-8.

PMID:
12398827
20.

Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.

Scardi S, Mazzone C, Pandullo C, Goldstein D, Di Lenarda A, Chersevani D.

G Ital Cardiol. 1999 Jun;29(6):637-46. English, Italian.

PMID:
10396667

Supplemental Content

Support Center